Contraception and family planning market — the commercial market for hormonal contraceptives, intrauterine devices, barrier methods, and emergency contraception representing the reproductive health dimension adjacent to but connected with maternal health — creates the family planning market that prevents unintended pregnancies and supports maternal health through birth spacing, with the Maternal Health Market reflecting contraception as an important adjacent maternal health market.

Long-acting reversible contraception market growth — the increasing IUD and hormonal implant adoption representing LARC's position as the most effective reversible contraception — creates the procedural contraceptive device market. The Mirena, Kyleena, and Liletta hormonal IUD market from Bayer and Medicines360, alongside the Paragard copper IUD, represent the US LARC market that ACOG promotion of LARC as first-line contraception has grown. Nexplanon (etonogestrel) implant market has similarly grown from healthcare provider and patient education about highly effective long-acting contraception.

Digital contraception and cycle tracking market — Clue Period Tracker, Natural Cycles FDA-cleared fertility awareness app, and connected basal body temperature devices representing the digital contraception and cycle awareness market — have grown substantially from smartphone adoption. Natural Cycles' FDA clearance as the first digital birth control represents the regulatory validation of evidence-based digital contraception, though with efficacy inferior to hormonal methods and LARC.

Post-Dobbs reproductive health market disruption — the Supreme Court Dobbs decision overturning Roe v. Wade and subsequent state abortion restrictions creating profound changes in reproductive healthcare access across approximately twenty US states — has created market disruptions in contraception access, emergency contraception demand, and telehealth reproductive health services that the commercial reproductive health market has responded to through expanded pharmacy dispensing (Plan B OTC) and telehealth abortion pill services in permissive states.

Do you think the Dobbs decision has created lasting commercial market opportunities for digital health and telehealth companies serving reproductive health needs, or will ongoing legal challenges create too much regulatory uncertainty for sustainable commercial investment?

FAQ

What is LARC and why is it recommended? Long-acting reversible contraceptives include intrauterine devices (IUDs) and subdermal implants; LARC has greater than ninety-nine percent efficacy (comparable to permanent sterilization) from eliminating user error; types: levonorgestrel IUDs (Mirena 5 years, Kyleena 5 years, Liletta 8 years, Skyla 3 years) — reduce menstrual bleeding, excellent for dysmenorrhea; copper IUD Paragard (10 years) — non-hormonal, can be used as emergency contraception; etonogestrel implant Nexplanon (3 years) — requires no user action; ACOG recommends LARC as first-line for all reproductive-age women; cost-effective over time despite higher upfront cost; immediately reversible with return to fertility; recommended for adolescents and nulliparous women.

What is Natural Cycles digital birth control? Natural Cycles is an FDA-cleared mobile app using an algorithm to predict daily fertility status (red days = fertile, green days = not fertile) based on basal body temperature input; requires daily morning temperature measurement with a dedicated thermometer; FDA-cleared as a prescription contraceptive app in the US (Class II medical device); typical use failure rate approximately six to seven percent (versus zero-point-one to zero-point-eight percent for IUD/implant); perfect use failure rate approximately one to two percent; not recommended for women with irregular cycles, shift workers, or women seeking highly effective contraception; suitable for women comfortable with fertility awareness method who prefer non-hormonal approach; requires consistent temperature measurement discipline.

#MaternalHealth #ContraceptionMarket #LARCmarket #DigitalContraception #FamilyPlanningMarket #ReproductiveHealth